These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27354752)

  • 1. Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights.
    Rose B
    Hosp Pharm; 2016 Jun; 51(6):491-2. PubMed ID: 27354752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights.
    Klafehn CW
    Hosp Pharm; 2016 Sep; 51(8):688-691. PubMed ID: 27698510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights.
    Rubio T
    Hosp Pharm; 2016 Mar; 51(3):268. PubMed ID: 38745575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights October - December 2016.
    Rose BJ
    Hosp Pharm; 2017 Feb; 52(2):153-154. PubMed ID: 28321144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights July-September 2016.
    Rubio T
    Hosp Pharm; 2016 Dec; 51(11):941-943. PubMed ID: 28057955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs.
    Garg V; Raisch DW; McKoy JM; Trifilio SM; Holbrook J; Edwards BJ; Belknap SM; Samaras AT; Nardone B; West DP
    Expert Opin Drug Saf; 2013 May; 12(3):299-307. PubMed ID: 23480866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Pre-marketing Factors to Predict Post-marketing Boxed Warnings and Safety Withdrawals.
    Schick A; Miller KL; Lanthier M; Dal Pan G; Nardinelli C
    Drug Saf; 2017 Jun; 40(6):497-503. PubMed ID: 28342075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.
    Yeh JS; Sarpatwari A; Kesselheim AS
    Drug Saf; 2016 Aug; 39(8):709-14. PubMed ID: 27000800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA boxed warnings: how to prescribe drugs safely.
    O'Connor NR
    Am Fam Physician; 2010 Feb; 81(3):298-303. PubMed ID: 20112888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summaries of safety labeling changes approved by FDA-boxed warnings highlights January-March 2016.
    Am J Health Syst Pharm; 2016 Jun; 73(11):e375-7. PubMed ID: 27208062
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study.
    Mostaghim SR; Gagne JJ; Kesselheim AS
    BMJ; 2017 Sep; 358():j3837. PubMed ID: 28882831
    [No Abstract]   [Full Text] [Related]  

  • 12. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March 2017.
    Office of Health and Constituent Affairs, U.S. Food and Drug Administration
    Am J Health Syst Pharm; 2017 Jun; 74(11):e292-e294. PubMed ID: 28546306
    [No Abstract]   [Full Text] [Related]  

  • 13. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, January-March 2019.
    Am J Health Syst Pharm; 2019 Jun; 76(13):e8-e9. PubMed ID: 31361888
    [No Abstract]   [Full Text] [Related]  

  • 14. Summaries of Safety Labeling Changes Approved By FDA—Boxed Warnings Highlights January-March 2015.
    Rubio T
    Am J Health Syst Pharm; 2015 Jun; 72(11):900, 902, 904. PubMed ID: 25987678
    [No Abstract]   [Full Text] [Related]  

  • 15. Summaries of safety labeling changes approved by FDA-boxed warnings highlights January-March 2016.
    Am J Health Syst Pharm; 2016 Jun; 73(11):739-40. PubMed ID: 27208054
    [No Abstract]   [Full Text] [Related]  

  • 16. "Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.
    Murphy S; Roberts R
    J Allergy Clin Immunol; 2006 Jan; 117(1):34-9. PubMed ID: 16387581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summaries of safety labeling changes approved by FDA-Boxed Warnings Highlights October-December 2014.
    Rubio T
    Am J Health Syst Pharm; 2015 Mar; 72(5):343. PubMed ID: 25694404
    [No Abstract]   [Full Text] [Related]  

  • 18. Summaries of Safety Labeling Changes Approved By FDA-Boxed Warnings Highlights April-June 2015.
    Am J Health Syst Pharm; 2015 Sep; 72(17):1430. PubMed ID: 26294231
    [No Abstract]   [Full Text] [Related]  

  • 19. Summaries of safety labeling changes approved by FDA-boxed warnings highlights, January-March 2024.
    Am J Health Syst Pharm; 2024 Jun; 81(13):e330-e334. PubMed ID: 38801728
    [No Abstract]   [Full Text] [Related]  

  • 20. Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights January - March 2017.
    Klafehn CW; Williams A
    Hosp Pharm; 2017 May; 52(5):327-329. PubMed ID: 28804146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.